Information
-
Trademark
-
97728916
-
International Classifications
-
Filing Date
December 22, 2022
2 years ago
-
Transaction Date
June 13, 2024
6 months ago
-
Status Date
June 10, 2024
7 months ago
-
Published for Opposition Date
October 17, 2023
a year ago
-
Location Date
December 12, 2023
a year ago
-
Status Code
730
-
Current Location
INTENT TO USE SECTION
Employee Name
TOOLEY, DAVID E
-
Attorney Docket Number
3309.0170001
Law Office Assigned Location Code
N70
-
Owners
Mark Drawing Code
4
Mark Identification
ADCROZ
Case File Statements
- GS0051: pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
Case File Event Statements
-
12/26/2022 - 2 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
12/27/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
6/15/2023 - a year ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/15/2023 - a year ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/15/2023 - a year ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/15/2023 - a year ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/13/2023 - a year ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/13/2023 - a year ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/13/2023 - a year ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
9/14/2023 - a year ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/27/2023 - a year ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/17/2023 - a year ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/17/2023 - a year ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
12/12/2023 - a year ago
14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
6/10/2024 - 7 months ago
15 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
6/10/2024 - 7 months ago
16 - SOU EXTENSION 1 FILED
Type: EXT1
-
6/10/2024 - 7 months ago
17 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
6/13/2024 - 6 months ago
18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA